Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea

被引：0

作者：

Kim, K. ^{[1
]}

Hong, S. N. ^{[2
]}

Kang, S. B. ^{[3
]}

Lee, K. M. ^{[4
]}

Koo, J. S. ^{[5
]}

Jung, Y. ^{[6
]}

Yoon, H. ^{[7
]}

Lee, B. J. ^{[8
]}

Lee, H. S. ^{[9
]}

Lee, Y. J. ^{[10
]}

Lim, Y. J. ^{[11
]}

Lee, J. ^{[12
]}

Lee, C. K. ^{[13
]}

Shin, S. Y. ^{[14
]}

Moon, J. M. ^{[14
]}

Seo, J. ^{[1
]}

Lim, H. ^{[1
]}

Choi, C. H. ^{[1
]}

机构：

[1] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea

[3] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Internal Med, Daejeon, South Korea

[4] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med, Suwon, South Korea

[5] Korea Univ, Coll Med, Dept Internal Med, Ansan, South Korea

[6] Soonchunhyang Univ, Coll Med, Dept Internal Med, Cheonan, South Korea

[7] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea

[8] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[9] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea

[10] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea

[11] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea

[12] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea

[13] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea

[14] Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Gwangmyeong, South Korea

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0934

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0760

引用

页码：I1466 / I1467

页数：2

共 50 条

[1] CLINICAL EFFICACY AND DURABILITY OF SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER SWITCHING FROM INTRAVENOUS INFLIXIMAB: A REAL-WORLD MULTICENTER PROSPECTIVE COHORT STUDY IN KOREA
Kim, Kyuwon
Hong, Sung Noh
Kang, Sang-Bum
Lee, Kang-Moon
Koo, Ja Seol
Jung, Yunho
Lee, Beom Jae
Yoon, Hyuk
Kim, Hyung Wook
Lim, Yun Jeong
Lee, Hyun Seok
Lee, Yoo Jin
Lee, Jun
Lee, Chang Kyun
Moon, Jung Min
Shin, Seung Yong
Seo, Jeongkuk
Choi, Chang Hwan
GASTROENTEROLOGY, 2024, 166 (05) : S1136 - S1136
[2] Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study
Kim, K.
Hong, S. N.
Kang, S. B.
Lee, K. M.
Koo, J. S.
Jung, Y.
Lee, B. J.
Yoon, H.
Kim, H. W.
Lim, Y. J.
Lee, H. S.
Lee, Y. J.
Lee, J.
Lee, C. K.
Shin, S. Y.
Moon, J. M.
Seo, J.
Choi, C. H.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1007 - I1009
[3] CLINICAL EFFICACY AND DURABILITY OF SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH MODERATE-TO-SEVERE INFLAMMATORY BOWEL DISEASE: A REAL-WORLD MULTICENTER PROSPECTIVE COHORT STUDY IN KOREA
Kim, Kyuwon
Hong, Sung Noh
Kang, Sang-Bum
Lee, Kang-Moon
Koo, Ja Seol
Jung, Yunho
Lee, Beom Jae
Yoon, Hyuk
Kim, Hyung Wook
Lim, Yun Jeong
Lee, Hyun Seok
Lee, Yoo Jin
Lee, Jun
Lee, Chang Kyun
Moon, Jung Min
Shin, Seung Yong
Seo, Jeongkuk
Choi, Chang Hwan
GASTROENTEROLOGY, 2024, 166 (05) : S1137 - S1137
[4] PERSISTENCE, EFFICACY AND TOLERANCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCH FROM INTRAVENOUS INFLIXIMAB IN IBD PATIENTS IN REMISSION:: ONE-TEAR RESULTS FROM A MULTICENTER PROSPECTIVE COHORT
Mathieu, Nicolas
Heluwaert, Frederic
Riviere, Pauline
Hebuterne, Xavier
Chupin, Antoine
Abitbol, Vered
Guillaume, Bouguen
Vuitton, Lucine
Allez, Matthieu
Montuclard, Celine
Nancey, Stephane
Biron, Amelie
Wils, Pauline
Gilletta, Cyrielle
de Maissin, Astrid
Altwegg, Romain
Chanteloup, Elise
Plastaras, Laurianne
Soune, Philippe Ah
Bourreille, Arnaud
Bouhnik, Yoram
Seksik, Philippe
Simon, Marion
Uzzan, Mathieu
andrau, Pierre
Rouillon, Clea
Arondel, Yves
Peyrin-Biroulet, Laurent
Laharie, David
Vicaut, Eric
Hupe, Marianne
GASTROENTEROLOGY, 2024, 166 (05) : S282 - S282
[5] Persistence, efficacy and tolerance of subcutaneous Infliximab after switch from intravenous infliximab in IBD patients in remission: one-year results from a multicenter prospective cohort
Mathieu, N.
Heluwaert, F.
Riviere, P.
Hebuterne, X.
Chupin, A.
Abitbol, V.
Bouguen, G.
Vuitton, L.
Allez, M.
Montuclard, C.
Nancey, S.
Biron, A.
Wils, P.
Gilletta, C.
De Maissin, A.
Altwegg, R.
Chanteloup, E.
Plastaras, L.
Ah-Soune, P.
Bourreille, A.
Bouhnik, Y.
Seksik, P.
Simon, M.
Uzzan, M.
Andrau, P.
Rouillon, C.
Arondel, Y.
Peyrin-Biroulet, L.
Laharie, D.
Vicaut, E.
Hupe, M.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1645 - I1645
[6] Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
Guerra Veloz, Maria Fernanda
Belvis Jimenez, Maria
Valdes Delgado, Teresa
Castro Laria, Luisa
Maldonado Perez, Belen
Perea Amarillo, Raul
Merino Bohorquez, Vicente
Caunedo Alvarez, Angel
Vilches Arenas, Angel
Arguelles-Arias, Federico
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
[7] Long-term, real-world efficacy of infliximab for psoriasis
Mercieca, L.
Warren, R. B.
Griffiths, C. E. M.
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E301 - E301
[8] SWITCHING INFLIXIMAB TO SUBCUTANEOUS FROM INTRAVENOUS THERAPY (SWIMSUIT) - A PROSPECTIVE, REAL-WORLD PHASE IV INTERVENTIONAL STUDY
Rahmany, Sohail
Young, David
Moyses, Helen
Gonclaves, Joao
Latter, Sue
Cummings, Fraser
GUT, 2023, 72 (SUPPL_2) : A92 - A93
[9] Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patients
Huguet, J. M.
Iborra, M.
Marti, L.
Bosca-Watts, M. M.
Ramirez, J. J.
Ruiz, L.
Sanchis, L.
Garrido, A.
Alemany, G.
Suria, C.
Paredes, J. M.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1242 - I1242
[10] Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
Oh, Shin Ju
Shin, Ga Young
Soh, Hosim
Lee, Jae Gon
Im, Jong Pil
Eun, Chang Soo
Lee, Kang-Moon
Park, Dong Il
Han, Dong Soo
Kim, Hyo Jong
Lee, Chang Kyun
INTESTINAL RESEARCH, 2021, 19 (03) : 323 - 331

← 1 2 3 4 5 →